Particle.news

Download on the App Store

Study Links Statin Use to 39% Drop in Sepsis Mortality

The analysis applied propensity score matching on more than 12,000 ICU records to probe how statins’ anti-inflammatory properties affect survival in sepsis.

Image
Image
Image

Overview

  • Statin therapy was linked with a 39% relative reduction in 28-day all-cause mortality among critically ill sepsis patients.
  • Researchers used data from the MIMIC-IV database spanning 2008 to 2019 to form two balanced cohorts of 6,070 patients each.
  • Patients treated with statins required an average of three additional hours of mechanical ventilation and 26 extra hours of continuous renal replacement therapy.
  • Survival benefits were observed in patients with normal, overweight or obese BMI but not in underweight individuals.
  • Investigators call for large, randomized trials to confirm causality and to determine optimal statin dosing and timing in sepsis care.